Weyerhaeuser Co (WY) reports a 25% increase in fourth-quarter adjusted EBITDA, while navigating challenging market conditions ...

Novartis AG (NVS) reports robust financial performance with significant product sales growth, while addressing potential ...

Q4 2024 Earnings Conference Call January 31, 2025 11:00 AM ETCompany ParticipantsKaren Bauer - Vice President, ...

Welcome to the OneMain Financial Fourth Quarter 2024 Earnings Conference Call and Webcast. Hosting the call today from OneMain is Peter Poillon, Head of Investor Relations. Today's call is being ...

Charter Communications reported a strong performance for the fourth quarter of 2024, surpassing earnings expectations and ...

Business First Bancshares Inc. (NASDAQ:BFST) reported its fourth-quarter 2024 earnings with a notable performance, surpassing ...

Operator: Good morning and thank you for joining us for Marine Products Corporation Fourth Quarter and Year End 2024 ...

Blue Foundry Bancorp (NASDAQ: BLFY) Q4 2024 Earnings Call Transcript January 29, 2025 ...

Blackstone Secured Lending Fund (NYSE: BXSL) (the “Company”) announced today that it will host its fourth quarter and full year 2024 investor conferen ...

Chevron reported fourth-quarter earnings below Wall Street estimates on Friday as weak margins dragged its refining business ...

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

Earnings were weaker than expected, the near-term outlook is murky, EV sales are down, and Elon Musk is more distracted than ever before. But with a phalanx of loyal shareholders and a cowed board ...